Monplast FX Suspension contains Montelukast and Fexofenadine, a synergistic anti-allergic combination formulated to manage allergic rhinitis, seasonal allergies, urticaria, and respiratory hypersensitivity conditions. It helps in reducing sneezing, runny nose, itching, nasal congestion, and watery eyes.
Montelukast acts as a leukotriene receptor antagonist to control allergic inflammation, while Fexofenadine works as a non-sedating antihistamine providing fast and long-lasting relief from allergy symptoms.
Suspension form ensures easy dosing and better compliance, especially in pediatric and adolescent patients. Its proven efficacy and safety profile make it a preferred choice in allergy and respiratory care practice.
Adding Monplast FX Suspension to your anti-allergic and respiratory portfolio strengthens your offerings with a high-rotation, season-independent product. Its strong prescription demand, pediatric suitability, and export potential make it ideal for PCD pharma companies, distributors, and third-party manufacturing partners.